JOHNSON & JOHNSON

JNJ · Pharmaceutical Preparations · 2.41B shares · -1%/yr ↓ buyback · EDGAR filings ↗

Net buyback after stock comp: $3.9B (gross $5.1B, SBC $1.2B)

Reference price $241.15 · est. market cap ~$580.5B — last insider sale, 2026-06-11 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

A86

Blue-chip diversified healthcare franchise with top-decile returns, cash generation and a fortress balance sheet.

Strengths

Top-decile ROA (13.5%, 94.3rd pct), net margin 28.5% (90.1st), FCF $19.7B (100th pct) and $20B cash (100th)
Durable, broadly diversified Innovative Medicine + MedTech moat with 6% sales growth

Risks

STELARA biosimilar erosion (-6.2% worldwide drag) and ongoing talc litigation overhang
Thin near-term liquidity (quick ratio 0.77, 12.3rd pct)

Notable findings

Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
Strong balance sheetStrong balance sheet — $20.1B cash & investments
FDA approvalFDA clearance/approval — TECNIS Eyhance Toric II IOLs with SmartLOAD Delivery Technology (GIU150-600) (2026-05-19)
Notable holderHeld by 5 notable fund(s): STATE STREET CORP, FMR LLC, GOLDMAN SACHS GROUP INC +2 more (as of 2026-03-31)
Insider sellingInsider selling — 18 open-market sale(s) by 8 insider(s) (cluster of 8 insiders, ~$83M, last 6mo) Form 4 ↗

Quarterly revenue

2025-06-29 · $23.7B2025-09-28 · $24.0B2025-12-28 · $24.6B2026-03-29 · $24.1B

Last 4 quarters · from SEC filings.

Key metrics

Gross margin

67.9%

Net margin

28.5%

Return on assets

13.5%

Revenue growth (QoQ)

-2.0%

Net-income growth

90.6%

Current ratio

1.0×

Free cash flow

$19.7B

Cash & investments

$20.1B

Stock comp / revenue

1.4%

Insider transactions · last 18 months

Date	Insider	Type	Shares	Price
2026-06-11	Wengel Kathryn E	Sell	10K	$241.15
2026-06-11	Wengel Kathryn E	Option exercise	10K	$115.67
2026-05-01	REED JOHN C	Option exercise	25K	—
2026-05-01	REED JOHN C	Tax withheld	11K	$229.85
2026-02-27	Decker Robert J	Sell	4.1K	$247.87
2026-02-27	Decker Robert J	Option exercise	4.1K	$115.67
2026-02-20	Schmid Timothy	Sell	1.3K	$245.66
2026-02-18	Schmid Timothy	Sell	9.0K	$244.53
2026-02-18	Schmid Timothy	Option exercise	9.0K	$129.51
2026-02-18	Schmid Timothy	Sell	14K	$244.20
2026-02-18	Schmid Timothy	Option exercise	14K	$115.67
2026-02-17	Wolk Joseph J	Option exercise	19K	$115.67
2026-02-17	REED JOHN C	Sell	2.3K	$243.00
2026-02-17	REED JOHN C	Sell	30K	$243.00
2026-02-17	REED JOHN C	Option exercise	30K	$156.15
2026-02-17	Wolk Joseph J	Sell	19K	$242.99
2026-02-17	Wolk Joseph J	Option exercise	12K	$129.51
2026-02-17	Wolk Joseph J	Sell	12K	$242.87
2026-02-17	Wolk Joseph J	Option exercise	33K	$131.94
2026-02-17	Swanson James D.	Option exercise	21K	$164.62
2026-02-17	Swanson James D.	Sell	21K	$242.70
2026-02-17	REED JOHN C	Sell	22K	$243.00
2026-02-17	REED JOHN C	Option exercise	22K	$157.92
2026-02-17	Wolk Joseph J	Sell	25K	$242.68
2026-02-17	Wolk Joseph J	Sell	33K	$242.75
2026-02-17	Broadhurst Vanessa	Sell	6.2K	$243.39
2026-02-15	Wengel Kathryn E	Tax withheld	325	$243.45
2026-02-15	Swanson James D.	Option exercise	492	—
2026-02-15	Swanson James D.	Tax withheld	214	$243.45
2026-02-15	Swanson James D.	Option exercise	709	—
2026-02-15	Swanson James D.	Tax withheld	309	$243.45
2026-02-15	Wengel Kathryn E	Option exercise	606	—
2026-02-15	Wengel Kathryn E	Tax withheld	310	$243.45
2026-02-15	Wengel Kathryn E	Option exercise	635	—
2026-02-15	Mulholland Kristen	Option exercise	419	—
2026-02-15	Mulholland Kristen	Tax withheld	172	$243.45
2026-02-15	Mulholland Kristen	Option exercise	575	—
2026-02-15	Mulholland Kristen	Tax withheld	251	$243.45
2026-02-15	Wolk Joseph J	Option exercise	2.0K	—
2026-02-15	Wolk Joseph J	Tax withheld	858	$243.45
2026-02-15	Wolk Joseph J	Option exercise	1.9K	—
2026-02-15	Wolk Joseph J	Tax withheld	817	$243.45
2026-02-15	Decker Robert J	Option exercise	339	—
2026-02-15	Decker Robert J	Tax withheld	94	$243.45
2026-02-15	Decker Robert J	Option exercise	344	—
2026-02-15	Decker Robert J	Tax withheld	95	$243.45
2026-02-15	REED JOHN C	Option exercise	1.3K	—
2026-02-15	REED JOHN C	Tax withheld	385	$243.45
2026-02-15	REED JOHN C	Option exercise	1.8K	—
2026-02-15	REED JOHN C	Tax withheld	528	$243.45
2026-02-15	Forminard Elizabeth	Option exercise	961	—
2026-02-15	Forminard Elizabeth	Tax withheld	492	$243.45
2026-02-15	Forminard Elizabeth	Option exercise	1.1K	—
2026-02-15	Forminard Elizabeth	Tax withheld	544	$243.45
2026-02-15	Taubert Jennifer L	Option exercise	1.6K	—
2026-02-15	Taubert Jennifer L	Tax withheld	816	$243.45
2026-02-15	Taubert Jennifer L	Option exercise	1.8K	—
2026-02-15	Taubert Jennifer L	Tax withheld	945	$243.45
2026-02-15	Schmid Timothy	Option exercise	1.0K	—
2026-02-15	Schmid Timothy	Tax withheld	15	$243.45
2026-02-15	Schmid Timothy	Option exercise	1.0K	—
2026-02-15	Schmid Timothy	Tax withheld	448	$243.45
2026-02-15	Duato Joaquin	Option exercise	3.7K	—
2026-02-15	Duato Joaquin	Tax withheld	1.6K	$243.45
2026-02-15	Duato Joaquin	Option exercise	4.5K	—
2026-02-15	Duato Joaquin	Tax withheld	2.0K	$243.45
2026-02-15	Broadhurst Vanessa	Option exercise	492	—
2026-02-15	Broadhurst Vanessa	Tax withheld	252	$243.45
2026-02-15	Broadhurst Vanessa	Option exercise	526	—
2026-02-15	Broadhurst Vanessa	Tax withheld	270	$243.45
2026-02-13	Forminard Elizabeth	Tax withheld	314	$244.55
2026-02-13	Forminard Elizabeth	Option exercise	14K	—
2026-02-13	Forminard Elizabeth	Tax withheld	7.0K	$244.55
2026-02-13	Swanson James D.	Tax withheld	3.5K	$244.55
2026-02-13	Swanson James D.	Option exercise	9.4K	—
2026-02-13	Swanson James D.	Tax withheld	143	$244.55
2026-02-13	Duato Joaquin	Option exercise	3.5K	—
2026-02-13	Taubert Jennifer L	Option exercise	1.3K	—
2026-02-13	Taubert Jennifer L	Tax withheld	409	$244.55
2026-02-13	Taubert Jennifer L	Option exercise	27K	—
2026-02-13	Taubert Jennifer L	Tax withheld	14K	$244.55
2026-02-13	Duato Joaquin	Tax withheld	989	$244.55
2026-02-13	Wolk Joseph J	Tax withheld	16K	$244.55
2026-02-13	Wolk Joseph J	Option exercise	1.8K	—
2026-02-13	Wolk Joseph J	Tax withheld	507	$244.55
2026-02-13	Duato Joaquin	Option exercise	73K	—
2026-02-13	Duato Joaquin	Tax withheld	32K	$244.55
2026-02-13	Broadhurst Vanessa	Tax withheld	144	$244.55
2026-02-13	Schmid Timothy	Option exercise	499	—
2026-02-13	Wolk Joseph J	Option exercise	37K	—
2026-02-13	Mulholland Kristen	Tax withheld	1.0K	$244.55
2026-02-13	Mulholland Kristen	Option exercise	3.6K	—
2026-02-13	Mulholland Kristen	Tax withheld	135	$244.55
2026-02-13	Mulholland Kristen	Option exercise	410	—
2026-02-13	Wengel Kathryn E	Tax withheld	6.4K	$244.55
2026-02-13	Wengel Kathryn E	Option exercise	14K	—
2026-02-13	Decker Robert J	Option exercise	312	—
2026-02-13	Decker Robert J	Tax withheld	104	$244.55
2026-02-13	Decker Robert J	Option exercise	2.7K	—
2026-02-13	Decker Robert J	Tax withheld	762	$244.55
2026-02-13	Schmid Timothy	Tax withheld	8	$244.55
2026-02-13	Schmid Timothy	Option exercise	4.4K	—
2026-02-13	Schmid Timothy	Tax withheld	1.8K	$244.55
2026-02-13	Broadhurst Vanessa	Option exercise	8.6K	—
2026-02-13	Broadhurst Vanessa	Tax withheld	3.7K	$244.55
2026-02-13	Swanson James D.	Option exercise	447	—
2026-02-13	Broadhurst Vanessa	Option exercise	408	—
2026-02-13	Swanson James D.	Option exercise	19K	$165.89
2026-02-13	Wengel Kathryn E	Tax withheld	217	$244.55
2026-02-13	Wengel Kathryn E	Option exercise	651	—
2026-02-13	Swanson James D.	Sell	22K	$243.71
2026-02-13	Swanson James D.	Option exercise	22K	$162.75
2026-02-13	Swanson James D.	Sell	19K	$243.76
2026-02-13	Forminard Elizabeth	Option exercise	651	—
2026-02-06	Mulholland Kristen	Option exercise	5.6K	$101.87
2026-02-06	Schmid Timothy	Option exercise	16K	$101.87
2026-02-06	Schmid Timothy	Tax withheld	10K	$239.99
2026-02-06	Mulholland Kristen	Tax withheld	3.3K	$239.99
2026-02-06	Wengel Kathryn E	Option exercise	39K	$101.87
2026-02-06	Wengel Kathryn E	Tax withheld	27K	$239.99
2026-02-05	Forminard Elizabeth	Option exercise	8.9K	$129.51
2026-02-05	Forminard Elizabeth	Tax withheld	6.2K	$237.90
2026-01-26	Duato Joaquin	Sell	49K	$221.48
2026-01-26	Duato Joaquin	Sell	51K	$220.99
2025-11-26	MORIKIS JOHN G	Buy	1.2K	$206.15
2025-10-17	REED JOHN C	Option exercise	22K	$157.92
2025-10-17	REED JOHN C	Sell	22K	$192.71
2025-09-04	Taubert Jennifer L	Sell	56K	$177.81
2025-09-04	Taubert Jennifer L	Option exercise	56K	$101.87
2025-08-29	Forminard Elizabeth	Option exercise	12K	$115.67
2025-08-29	Forminard Elizabeth	Tax withheld	9.6K	$177.20
2025-08-22	Duato Joaquin	Option exercise	126K	$101.87
2025-08-22	Duato Joaquin	Sell	126K	$179.21
2025-08-15	Wolk Joseph J	Sell	17K	$176.91
2025-08-15	Wolk Joseph J	Option exercise	17K	$101.87
2025-07-17	REED JOHN C	Sell	19K	$163.55
2025-05-01	REED JOHN C	Tax withheld	11K	$156.31
2025-05-01	REED JOHN C	Option exercise	25K	—
2025-03-18	Duato Joaquin	Gift	131K	—
2025-03-18	Duato Joaquin	Gift	131K	—
2025-02-25	Decker Robert J	Sell	7.0K	$165.88
2025-02-25	Decker Robert J	Option exercise	7.0K	$101.87
2025-02-18	Wolk Joseph J	Tax withheld	768	$156.15
2025-02-18	REED JOHN C	Tax withheld	385	$156.15
2025-02-18	Taubert Jennifer L	Tax withheld	651	$156.15
2025-02-18	Duato Joaquin	Tax withheld	1.6K	$156.15
2025-02-18	Swanson James D.	Tax withheld	141	$156.15
2025-02-18	Broadhurst Vanessa	Tax withheld	158	$156.15
2025-02-18	Mulholland Kristen	Tax withheld	120	$156.15
2025-02-18	Schmid Timothy	Sell	403	$156.15
2025-02-18	Forminard Elizabeth	Tax withheld	307	$156.15
2025-02-18	Wengel Kathryn E	Tax withheld	200	$156.15
2025-02-18	Decker Robert J	Tax withheld	94	$156.15
2025-02-15	Decker Robert J	Option exercise	339	—
2025-02-15	Wengel Kathryn E	Option exercise	607	—
2025-02-15	Wolk Joseph J	Option exercise	2.0K	—
2025-02-15	Schmid Timothy	Option exercise	1.0K	—
2025-02-15	Duato Joaquin	Option exercise	3.7K	—
2025-02-15	REED JOHN C	Option exercise	1.4K	—
2025-02-15	Swanson James D.	Option exercise	492	—
2025-02-15	Taubert Jennifer L	Option exercise	1.6K	—
2025-02-15	Broadhurst Vanessa	Option exercise	492	—
2025-02-15	Mulholland Kristen	Option exercise	419	—
2025-02-15	Forminard Elizabeth	Option exercise	961	—
2025-02-14	Duato Joaquin	Tax withheld	2.2K	$156.71
2025-02-14	Schmid Timothy	Option exercise	2.8K	—
2025-02-14	Schmid Timothy	Tax withheld	1.0K	$156.71
2025-02-14	Schmid Timothy	Tax withheld	193	$155.26
2025-02-14	Schmid Timothy	Option exercise	1.8K	—
2025-02-14	Schmid Timothy	Tax withheld	639	$156.71
2025-02-14	Wengel Kathryn E	Tax withheld	223	$155.26
2025-02-14	Wengel Kathryn E	Option exercise	1.5K	—
2025-02-14	Wengel Kathryn E	Tax withheld	480	$156.71
2025-02-14	Wengel Kathryn E	Option exercise	5.8K	—
2025-02-14	Wengel Kathryn E	Tax withheld	2.4K	$156.71
2025-02-14	Wolk Joseph J	Tax withheld	507	$155.26
2025-02-14	Wolk Joseph J	Option exercise	4.0K	—
2025-02-14	Wolk Joseph J	Tax withheld	1.1K	$156.71
2025-02-14	Wolk Joseph J	Option exercise	15K	—
2025-02-14	Wolk Joseph J	Tax withheld	6.7K	$156.71
2025-02-14	Taubert Jennifer L	Tax withheld	410	$155.26
2025-02-14	Taubert Jennifer L	Option exercise	4.1K	—
2025-02-14	Taubert Jennifer L	Tax withheld	1.3K	$156.71
2025-02-14	Taubert Jennifer L	Option exercise	15K	—
2025-02-14	Taubert Jennifer L	Tax withheld	7.9K	$156.71
2025-02-14	Swanson James D.	Tax withheld	152	$155.26
2025-02-14	Swanson James D.	Option exercise	2.0K	—
2025-02-14	Swanson James D.	Tax withheld	558	$156.71
2025-02-14	Swanson James D.	Option exercise	3.1K	—
2025-02-14	Swanson James D.	Tax withheld	889	$156.71
2025-02-14	Mulholland Kristen	Tax withheld	141	$155.26
2025-02-14	Mulholland Kristen	Option exercise	1.0K	—
2025-02-14	Mulholland Kristen	Tax withheld	290	$156.71
2025-02-14	Mulholland Kristen	Option exercise	1.6K	—
2025-02-14	Mulholland Kristen	Tax withheld	457	$156.71
2025-02-14	Forminard Elizabeth	Tax withheld	215	$155.26
2025-02-14	Forminard Elizabeth	Option exercise	851	—
2025-02-14	Forminard Elizabeth	Tax withheld	267	$156.71
2025-02-14	Forminard Elizabeth	Option exercise	1.4K	—
2025-02-14	Forminard Elizabeth	Tax withheld	464	$156.71
2025-02-14	Duato Joaquin	Tax withheld	1.5K	$155.26
2025-02-14	Duato Joaquin	Option exercise	5.1K	—
2025-02-14	Duato Joaquin	Option exercise	19K	—
2025-02-14	Duato Joaquin	Tax withheld	8.4K	$156.71
2025-02-14	Decker Robert J	Tax withheld	104	$155.26
2025-02-14	Decker Robert J	Option exercise	850	—
2025-02-14	Decker Robert J	Tax withheld	254	$156.71
2025-02-14	Decker Robert J	Option exercise	1.4K	—
2025-02-14	Decker Robert J	Tax withheld	372	$156.71
2025-02-14	Broadhurst Vanessa	Tax withheld	151	$155.26
2025-02-14	Broadhurst Vanessa	Option exercise	1.8K	—
2025-02-14	Broadhurst Vanessa	Tax withheld	574	$156.71
2025-02-14	Broadhurst Vanessa	Option exercise	2.9K	—
2025-02-14	Broadhurst Vanessa	Tax withheld	997	$156.71
2025-02-13	Wolk Joseph J	Option exercise	1.8K	—
2025-02-13	Duato Joaquin	Option exercise	3.5K	—
2025-02-13	Forminard Elizabeth	Option exercise	651	—
2025-02-13	Mulholland Kristen	Option exercise	411	—
2025-02-13	Swanson James D.	Option exercise	447	—
2025-02-13	Wengel Kathryn E	Option exercise	651	—
2025-02-13	Schmid Timothy	Option exercise	499	—
2025-02-13	Decker Robert J	Option exercise	312	—
2025-02-13	Taubert Jennifer L	Option exercise	1.3K	—
2025-02-13	Broadhurst Vanessa	Option exercise	408	—
2025-02-07	Wengel Kathryn E	Option exercise	33K	$100.06
2025-02-07	Wolk Joseph J	Option exercise	13K	$100.06
2025-02-07	Wengel Kathryn E	Tax withheld	26K	$153.12
2025-02-07	Wolk Joseph J	Sell	13K	$153.89
2025-02-07	Taubert Jennifer L	Option exercise	59K	$100.06
2025-02-07	Taubert Jennifer L	Tax withheld	47K	$153.12
2025-02-07	Duato Joaquin	Option exercise	126K	$100.06
2025-02-07	Duato Joaquin	Tax withheld	101K	$153.12

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

Trial	Title	Phase	Status	Primary completion
NCT06510205 ↗	The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population Breast Augmentation, Mammaplasty	—	Recruiting	2034-06-30
NCT06667908 ↗	A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung	PHASE2	Recruiting	2028-12-31
NCT06311578 ↗	A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors Neoplasms	PHASE1	Recruiting	2028-11-08
NCT07219212 ↗	A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma Squamous Cell Carcinoma of Head and Neck	PHASE1	Recruiting	2028-07-14
NCT04892173 ↗	JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC Carcinoma, Squamous Cell	PHASE3	Recruiting	2028-06-30
NCT07228312 ↗	A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms Intracranial Aneurysm	—	Recruiting	2028-02-10
NCT07525141 ↗	A Study of JNJ-1761981 in Participants With Solid Tumors Neoplasms	PHASE1	Recruiting	2028-01-12
NCT07141004 ↗	A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA) Arthritis, Psoriatic	PHASE4	Recruiting	2027-06-05
NCT06116786 ↗	A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer Carcinoma, Non-small-Cell Lung	PHASE1	Recruiting	2027-04-14
NCT07030517 ↗	A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma Multiple Myeloma	PHASE4	Recruiting	2026-11-03
NCT07324200 ↗	Objective Assessment of Intraocular Lens Tilt and Decentration Tilt and Decentration	—	Recruiting	2026-06-26
NCT07511166 ↗	A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation Atrial Fibrillation	—	Not Yet Recruiting	2028-02-09
NCT07443215 ↗	Evaluation of Effect of Scatter on Visual Performance Visual Acuity	NA	Completed	2026-05-22
NCT07218419 ↗	Comparison of Methods for Assessing Intraocular Lens Position Tilt and Decentration	—	Completed	2026-01-16
NCT07174596 ↗	Evaluation of Approved Contact Lenses Visual Acuity	NA	Completed	2025-10-27
NCT06778057 ↗	Clinical Performance of Three Daily Disposable Silicone Hydrogel Contact Lenses Visual Acuity	NA	Completed	2025-10-16
NCT07076160 ↗	Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses Visual Acuity, Presbyopia	NA	Completed	2025-09-20
NCT05634408 ↗	Evaluating ACUVUE® Abiliti™ 1-Day Soft Therapeutic Lenses for Myopia Management Visual Acuity	NA	Completed	2025-08-20
NCT06318637 ↗	Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates Newborn	NA	Completed	2025-08-12
NCT06075576 ↗	Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects Myopia	—	Completed	2025-08-11

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Supply chain

Customers (0)

Suppliers (3)

Named in the 10-K; linked when we track them.

Notable events (8-K)

Date	Items
2026-04-28	Shareholder voteExhibits	filing ↗
2026-04-14	ResultsOtherExhibits	filing ↗
2026-01-21	ResultsExhibits	filing ↗
2025-10-14	ResultsOtherExhibits	filing ↗
2025-09-09	Exec/director change	filing ↗
2025-07-16	ResultsExhibits	filing ↗
2025-06-10	Exec/director change	filing ↗
2025-04-30	Exec/director changeShareholder voteExhibits	filing ↗

Recent filings

Form	Filed	Period	Accession
8-K	2026-04-28	2026-04-23	0000200406-26-000089 ↗
10-Q	2026-04-22	2026-03-29	0000200406-26-000087 ↗
8-K	2026-04-14	2026-04-14	0000200406-26-000076 ↗
10-K	2026-02-11	2025-12-28	0000200406-26-000016 ↗
8-K	2026-01-21	2026-01-21	0000200406-26-000002 ↗
10-Q	2025-10-22	2025-09-28	0000200406-25-000209 ↗
8-K	2025-10-14	2025-10-14	0000200406-25-000201 ↗
8-K	2025-09-09	2025-09-08	0000200406-25-000190 ↗
10-Q	2025-07-24	2025-06-29	0000200406-25-000178 ↗
8-K	2025-07-16	2025-07-16	0000200406-25-000170 ↗
8-K	2025-06-10	2025-06-10	0000200406-25-000152 ↗
8-K	2025-04-30	2025-04-24	0000200406-25-000141 ↗